Substance active (DCI)
- guanfacine (chlorhydrate)
Informations techniques
Exploitant
Laboratoire NOVARTIS PHARMA
Présentation
ESTULIC 2 mg, comprimé
B/30 : CIP 323 305-8
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
DpsYzS5WnHrpBfvv